These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 22093838
1. [Norepinephrine-new milestone for treatment of shock]. Wu LJ. Zhonghua Yi Xue Za Zhi; 2011 Jul 19; 91(27):1873-4. PubMed ID: 22093838 [No Abstract] [Full Text] [Related]
2. Comparison of dopamine and norepinephrine in shock. Du B, Hu X, Weng L. N Engl J Med; 2010 Jun 17; 362(24):2330; author reply 2330-1. PubMed ID: 20560182 [No Abstract] [Full Text] [Related]
3. Comparison of dopamine and norepinephrine in shock. Paolo WF. N Engl J Med; 2010 Jun 17; 362(24):2330; author reply 2330-1. PubMed ID: 20560161 [No Abstract] [Full Text] [Related]
4. Treating shock--old drugs, new ideas. Levy JH. N Engl J Med; 2010 Mar 04; 362(9):841-3. PubMed ID: 20200389 [No Abstract] [Full Text] [Related]
6. Arginine vasopressin in vasodilatory shock. Fuchs FD, Filho JW. Circulation; 2003 Nov 11; 108(19):e141; author reply e141. PubMed ID: 14610004 [No Abstract] [Full Text] [Related]
7. Dopamine versus norepinephrine in the treatment of shock. Nathan Coxford R, Lang E, Dowling S. CJEM; 2011 Nov 11; 13(6):395-7. PubMed ID: 22436478 [Abstract] [Full Text] [Related]
8. Arginine vasopressin in advanced vasodilatory shock. De Backer D, Creteur J, Vincent JL. Circulation; 2003 Nov 11; 108(19):e142; author reply e142. PubMed ID: 14610005 [No Abstract] [Full Text] [Related]
9. Comparison of dopamine and norepinephrine in shock. Romero CM. N Engl J Med; 2010 Jun 17; 362(24):2328; author reply 2330-1. PubMed ID: 20554990 [No Abstract] [Full Text] [Related]
10. [Pressor amines and cardiogenic shock. An evalution with special reference to the use of noradrenaline]. Hillestad L. Tidsskr Nor Laegeforen; 1965 Nov 01; 85(21):1621-4. PubMed ID: 5882929 [No Abstract] [Full Text] [Related]
11. [Shock therapy with vasodilator and-or vasoconstrictor agents]. Wolff G, Gigon JP, Enderlin F. Helv Chir Acta; 1967 Feb 01; 34(1):26-31. PubMed ID: 4295568 [No Abstract] [Full Text] [Related]
12. The dilemma of vasopressors and vasodilators in the therapy of shock. Shoemaker WC, Brown RS. Surg Gynecol Obstet; 1971 Jan 01; 132(1):51-7. PubMed ID: 5538813 [No Abstract] [Full Text] [Related]
13. The authors reply. Annane D, Dellinger RP. Crit Care Med; 2013 Dec 01; 41(12):e484. PubMed ID: 24275413 [No Abstract] [Full Text] [Related]
14. [Basic principles of the therapy of shock]. Schröder R. Minerva Med; 1972 Dec 26; 63(93):5243-6. PubMed ID: 4646406 [No Abstract] [Full Text] [Related]
15. [Vasopressor drugs in shock due to myocardial infarction]. Adamska-Dyniewska H. Pol Tyg Lek; 1967 Oct 02; 22(45):1744-7. PubMed ID: 4294154 [No Abstract] [Full Text] [Related]
16. The treatment of cardiogenic shock. II. The use of pressor agents in the treatment of cardiogenic shock. Kuhn LA. Am Heart J; 1967 Nov 02; 74(5):725-8. PubMed ID: 6055703 [No Abstract] [Full Text] [Related]
17. [Therapy of shock using vaso- and coagulation-active substances. Behavior of tissue oxygen in the dog kidney under the influence of vaso- and coagulation-active substances]. Lenz J, Hartel W, Linder MM, Muschaweck R. Fortschr Med; 1972 Nov 16; 90(32):1199-201. PubMed ID: 4348841 [No Abstract] [Full Text] [Related]
19. "Vasopressor Support Sparing Strategies": a Concept to be Incorporated as a Paradigm in the Treatment of Vasodilatory Shock. Evora PRB, Braile DM. Braz J Cardiovasc Surg; 2019 Nov 16; 34(1):I-II. PubMed ID: 30810668 [No Abstract] [Full Text] [Related]
20. [Problems in the treatment of cardiogenic shock]. Heublein B, Parsi RA. Dtsch Gesundheitsw; 1970 Apr 23; 25(16):732-7. PubMed ID: 4320726 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]